NCT01329835

Brief Summary

Prepregnancy obesity, defined as a body mass index (BMI) of 30kg/m² or more, shows a strong association with pregnancy and birth complications for both the mother and her child. Most consequently reported maternal risks include an increased risk for gestational diabetes, hypertension and pre-eclampsia, increased incidence of induction of labour, operative delivery, postpartum haemorrhage, anaesthetic risks as well as risk for infections and thromboembolic complications. Fetal risks include miscarriage, neural-tube defects, heart defects, macrosomia and stillbirth. Initiation and continuation of breastfeeding is more complicated in obese women than in normal weight women. Also in later life chronic diseases can put the mother and her baby's health at risk. The Institute Of Medicine (IOM) guidelines suggest a gestational weight gain (GWG) to be limited to 5 - 9 kg (11-19,8 lb) in obese women in order to minimize the synergetic negative health consequences of excessive weight gain for both the obese mother and her child. Preventing excessive weight gain during pregnancy and postpartum weight retention is also important in the prevention of overweight and obesity among women of reproductive age. Obese women in general have a poor diet quality and are more exposed to psychosocial factors like anxiety and feelings of depression than normal weight women. The aim of this project is to perform a randomized controlled trial (RCT) in order to evaluate the effects of life-style intervention (psycho-education by a midwife during 4 prenatal sessions) on pregnancy and birth outcomes. Main dependent variables are gestational weight gain and anxiety and depression. Obesity is a modifiable risk factor and optimizing an adequate gestational weight gain with attention to psycho-social factors, can reduce the need for adverse perinatal outcomes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2008

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

March 30, 2011

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 6, 2011

Completed
2.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

December 6, 2011

Status Verified

July 1, 2008

Enrollment Period

3.1 years

First QC Date

March 30, 2011

Last Update Submit

December 5, 2011

Conditions

Outcome Measures

Primary Outcomes (1)

  • Gestational weight gain

    Weight just before delivery minus prepregnancy weight

    For the duration of pregnancy, an expected average of 40 weeks

Secondary Outcomes (1)

  • Evolutions in anxiety and depression during pregnancy

    During pregnancy on fixed time points: trimester 1 (before 15 weeks of gestation), trimester 2 (between 18 and 28 weeks of gestation) and trimester 3 (between 30 - 34 weeks of gestation)

Study Arms (3)

Written information via brochure

EXPERIMENTAL

Written information by a brochure

Other: brochure

standard care

NO INTERVENTION

standard prenatal care

Lifestyle counseling

EXPERIMENTAL

Psycho-education based on principles of motivational interviewing and positive reinforcement

Behavioral: Lifestyle counseling

Interventions

4 prenatal sessions based on principles of motivational interviewing and positive reinforcement

Lifestyle counseling

brochure given after randomization

Written information via brochure

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Less than 15 weeks pregnant

You may not qualify if:

  • Multiple pregnancy
  • Preexisting diabetes
  • Primary need for nutritional advice
  • Inadequate knowledge of Dutch language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

St-Jans Hospital ZOL

Genk, Limburg, 3600, Belgium

RECRUITING

Jessa Hospital

Hasselt, Limburg, 3500, Belgium

RECRUITING

SFZ

Heusden, Limburg, 3550, Belgium

RECRUITING

Study Officials

  • Roland Devlieger, PhD, MD

    Universitaire Ziekenhuizen KU Leuven

    STUDY DIRECTOR
  • Bea Van den Bergh, PhD

    University of Tilburg (Nl)

    STUDY DIRECTOR
  • Ingrid Witters, PhD, MD

    Universitaire Ziekenhuizen KU Leuven

    STUDY DIRECTOR
  • Annick Bogaerts, MW, MSc, PhDstudent

    KHLim PHL

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 30, 2011

First Posted

April 6, 2011

Study Start

March 1, 2008

Primary Completion

April 1, 2011

Study Completion

December 1, 2013

Last Updated

December 6, 2011

Record last verified: 2008-07

Locations